Zobrazeno 1 - 10
of 113
pro vyhledávání: '"Jude A, Oben"'
Autor:
Mandour O. Mandour, MBBS, Safa Al-Musawi, MBBS, Esther Idowu, MBBS, Paul F. Long, PhD, Ellie Rashidghamat, MBBS, Jude A. Oben, MD
Publikováno v:
JAAD Case Reports, Vol 34, Iss , Pp 23-26 (2023)
Externí odkaz:
https://doaj.org/article/736eb334bd6b4743b9c38b1858ed1d86
Autor:
Marco Raffaele, Kristina Kovacovicova, Jan Frohlich, Oriana Lo Re, Sebastiano Giallongo, Jude A. Oben, Martin Faldyna, Lenka Leva, Antonino Giulio Giannone, Daniela Cabibi, Manlio Vinciguerra
Publikováno v:
Cell Communication and Signaling, Vol 19, Iss 1, Pp 1-9 (2021)
Abstract Background Nonalcoholic fatty liver disease (NAFLD) is increasingly prevalent and represents a growing challenge in terms of prevention and treatment. A minority of affected patients develops inflammation, subsequently fibrosis, cirrhosis an
Externí odkaz:
https://doaj.org/article/4fcf741681b04f8ab57e1edf88a7ef33
Publikováno v:
World Journal of Hepatology. 14:1704-1717
Over the last decade, non-alcoholic fatty liver disease (NAFLD) has overtaken alcohol as the leading cause of cirrhosis in the Western world. There remains to be a licensed pharmacological treatment for NAFLD. Weight loss is advised for all patients
Autor:
Irma Magaly Rivas Serna, Ilaria Romito, Andrea Maugeri, Oriana Lo Re, Sebastiano Giallongo, Gianluigi Mazzoccoli, Jude A. Oben, Giovanni Li Volti, Tommaso Mazza, Anna Alisi, Manlio Vinciguerra
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 22, p 8452 (2020)
Lipid catabolism and anabolism changes play a role in stemness acquisition by cancer cells, and cancer stem cells (CSCs) are particularly dependent on the activity of the enzymes involved in these processes. Lipidomic changes could play a role in CSC
Externí odkaz:
https://doaj.org/article/3201d22e5ff445f08894bad3baf700bd
Autor:
Vi Nguyen, Jiawei Li, Jaslyn Gan, Paul Cordero, Shuvra Ray, Alessandro Solis-Cuevas, Mai Khatib, Jude A. Oben
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2017 (2017)
Background. The incidence of nonalcoholic fatty liver disease (NAFLD) continues to parallel the rise in obesity rates. Endobariatric devices such as the intragastric balloon (IGB) may provide an alternative treatment option. Methods. Outcomes followi
Externí odkaz:
https://doaj.org/article/0308cd1af8d1439fbcad1a03091b9ace
Autor:
Clarissa Elysia Fu, Cheng Han Ng, Jie Ning Yong, Kai En Chan, Jieling Xiao, Benjamin Nah, Shirley Huey Shin Bong, Khin Maung Win, Aung Hlaing Bwa, Wen Hui Lim, Darren Jun Hao Tan, Rebecca Wenling Zeng, Nicholas Chew, Margaret L.P. Teng, Mohammad Shadab Siddiqui, Jude A. Oben, Arun J. Sanyal, Vincent Wai-Sun Wong, Mazen Noureddin, Mark Muthiah
Publikováno v:
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
Nonalcoholic fatty liver disease (NAFLD) affects much of the worldwide population and poses a significant burden to the global healthcare. The rising numbers of individuals with NAFLD and instances of mortality point toward the importance of understa
Publikováno v:
EBioMedicine, Vol 28, Iss C, Pp 9-10 (2018)
Externí odkaz:
https://doaj.org/article/35eb6776b3bb4c96a5e499aff656e974
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 12:357-367
Obesity is the most prevalent noncommunicable disease in the 21st century, associated with triglyceride deposition in hepatocytes leading to nonalcoholic fatty liver disease (NAFLD). NAFLD is now present in around a third of the world's population. E
Autor:
Paul Cordero, Jiawei Li, Vi Nguyen, Joaquim Pombo, Nuria Maicas, Marco Novelli, Paul D. Taylor, Anne-Maj Samuelsson, Manlio Vinciguerra, Jude A. Oben
Publikováno v:
Nutrients, Vol 9, Iss 9, p 1041 (2017)
Maternal obesity predisposes offspring to metabolic dysfunction and Non-Alcoholic Fatty Liver Disease (NAFLD). Melanocortin-4 receptor (Mc4r)-deficient mouse models exhibit obesity during adulthood. Here, we aim to determine the influence of the Mc4r
Externí odkaz:
https://doaj.org/article/524bf496b0a444feb9a1f2bb881e4b80
Autor:
Rebeca Carter, Angelina Mouralidarane, Junpei Soeda, Shuvra Ray, Joaquim Pombo, Ruma Saraswati, Marco Novelli, Giuseppe Fusai, Francesca Rappa, Chiara Saracino, Valerio Pazienza, Lucilla Poston, Paul D Taylor, Manlio Vinciguerra, Jude A Oben
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e89505 (2014)
Emerging evidence suggests that maternal obesity (MO) predisposes offspring to obesity and the recently described non-alcoholic fatty pancreas disease (NAFPD) but involved mechanisms remain unclear. Using a pathophysiologically relevant murine model,
Externí odkaz:
https://doaj.org/article/62ffbba5fa094c259117c4d364798a9d